MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 113 filers reported holding MAXCYTE INC in Q1 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,721,204 | -31.1% | 5,038,847 | +1.4% | 0.00% | -100.0% |
| Q2 2023 | $22,816,569 | -5.7% | 4,970,930 | +1.7% | 0.00% | 0.0% |
| Q1 2023 | $24,197,942 | -8.6% | 4,888,473 | +0.8% | 0.00% | 0.0% |
| Q4 2022 | $26,470,718 | -12.7% | 4,848,117 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $30,324,000 | +88.8% | 4,665,320 | +37.4% | 0.00% | – |
| Q2 2022 | $16,061,000 | -30.0% | 3,395,510 | +3.4% | 0.00% | -100.0% |
| Q1 2022 | $22,958,000 | -28.7% | 3,284,596 | +4.0% | 0.00% | 0.0% |
| Q4 2021 | $32,177,000 | -4.3% | 3,157,690 | +14.6% | 0.00% | 0.0% |
| Q3 2021 | $33,630,000 | – | 2,754,317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 1,885,000 | $5,881,200 | 5.55% |
| Vitruvian Partners LLP | 5,043,356 | $15,735,271 | 4.46% |
| Stonepine Capital Management, LLC | 3,761,640 | $11,736,317 | 3.90% |
| Mudita Advisors LLP | 1,390,858 | $4,339,477 | 3.17% |
| RIVER GLOBAL INVESTORS LLP | 1,473,254 | $4,588,359 | 1.07% |
| Casdin Capital, LLC | 1,890,000 | $5,896,800 | 0.65% |
| Portolan Capital Management | 2,143,666 | $6,688,238 | 0.62% |
| Grandeur Peak Global Advisors, LLC | 1,434,819 | $4,476,635 | 0.34% |
| First Light Asset Management, LLC | 1,073,110 | $3,348,103 | 0.32% |
| Granahan Investment Management | 1,975,847 | $6,164,643 | 0.22% |